Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1-year interim results)

---

Copy For Citation

Vermersch P., Eralinna J. -., Nicholas R., Oreja-Guevara C., Siva A., Van Wijmeersch B., ...More

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, vol.25, pp.344-345

• Publication Type: Conference Paper / Summary Text
• Volume: 25
• City: Stockholm
• Country: Sweden
• Page Numbers: pp.344-345
• Istanbul University Affiliated: Yes